Salvus Health, the innovative pharmacy software platform, has received a capital injection of 500k EURO. This funding, made possible in part by business angels from BAN Flanders and Angelwise fund, will accelerate Salvus Health's expansion in Belgium and abroad.
In modern healthcare, pharmacists are not only essential suppliers of medicines but also crucial partners in patient care. Salvus Health responds to this by offering a platform that automates repetitive tasks, helping pharmacists manage their time more efficiently. This enables pharmacists to focus more on what they excel at: providing expert advice and enhancing patient adherence to therapies.
With over 150 pharmacies and more than 100.000 patients as clients, Salvus Health has already made an impressive impact in the sector. The capital injection will not only help the company strengthen its technological edge but also increase its market share within the 4.500 pharmacies in Belgium and explore opportunities beyond its borders.
Co-founders Philip Van den Bergh and Salvador Severich are determined to further transform the pharmacy industry with their platform. They believe Salvus Health not only gives pharmacists more time but also strengthens their role as healthcare providers.
With 27 years of experience in the global pharmaceutical industry, I am convinced that Salvus Health offers a valuable platform that enables pharmacists to expand their essential role in healthcare. The investment in Salvus Health is more than just capital; it combines knowledge and strategy to future-proof pharmacies.Jurgen De Baerdemaeker, business angel BAN Flanders
